Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
- Study Title
- Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
- Teva Identifier
- TNC GA MS 2004_01
- ClinicalTrials.gov Identifier
- NCT00203047
- Study Status
- Terminated
- Trial Condition(s)
- Relapsing Remitting Multiple Sclerosis
- Interventions
- Drug: Glatiramer Acetate | Drug: Placebo | Drug: Prednisone
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 55 Years
- Trial Duration
- 01/01/2005 - 05/01/2009
- Phase
- Phase 4
